Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension

Cephalalgia

Volumn 35, Issue 13, 2015, Pages 1153-1161

  Altlokka Uzun, Güneş ^a   Tüzün, Erdem ^b   Ekizoʇlu, Esme ^a   Ulusoy, Canan ^b   Yentür, Sibel ^a   Kürtüncü, Murat ^a   Saruhan Direskeneli, Güher ^a   Baykan, Betül ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

cytokine; idiopathic intracranial hypertension; immunology; Oligoclonal bands; vision loss

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; OLIGOCLONAL BAND; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD CELL COUNT; BODY MASS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE; VISUAL ACUITY; VISUAL IMPAIRMENT; BLOOD; CEREBROSPINAL FLUID; INTRACRANIAL HYPERTENSION; YOUNG ADULT;

ADULT; BIOMARKERS; CYTOKINES; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; OLIGOCLONAL BANDS; YOUNG ADULT;

EID: 84929364943     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415570762     Document Type: Article

References (27)

1. Friedman DI, Liu GT, Digre KB,. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81: 1159-1165.
2. Wakerley B, Tan M and Ting E. Idiopathic intracranial hypertension. Cephalalgia. 2015; 35: 248-261.
3. Sinclair AJ, Ball AK, Burdon MA, et al. Exploring the pathogenesis of IIH: An inflammatory perspective. J Neuroimmunol 2008; 201-202: 212-220.
4. McGeeney BE, Friedman DI,. Pseudotumor cerebri pathophysiology. Headache 2014; 54: 445-458.
5. Edwards LJ, Sharrack B, Ismail A, et al. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol 2013; 2: 234-244.
6. Zeman A, McLean B, Keir G, et al. The significance of serum oligoclonal bands in neurological diseases. J Neurol Neurosurg Psychiatry 1993; 56: 32-35.
7. Sinclair AJ, Wienholt L, Tantsis E, et al. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology. Dev Med Child Neurol 2013; 55: 71-75.
8. Dale RC, Brilot F,. Biomarkers of inflammatory and auto-immune central nervous system disorders. Curr Opin Pediatr 2010; 22: 718-725.
9. McLean BN, Luxton RW, Thompson EJ,. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 1990; 113: 1269-1289.
10. Inshasi JS, Gledhill RF, Keir G, et al. Intrathecal synthesis of IgG in benign intracranial hypertension: A re-examination. J Neurol 1995; 242: 593-595.
11. Saruhan-Direskeneli G, Yentür SP, Mutlu M, et al. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease. Clin Exp Rheumatol 2013; 31: 25-27.
12. Sádaba MC, González Porqué P, Masjuan J, et al. An ultrasensitive method for the detection of oligoclonal IgG bands. J Immunol Methods 2004; 284: 141-145.
13. Petzold A,. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 2013; 262: 1-10.
14. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. Arch Neurol 2005; 62: 865-870.
15. Elodie N, Mahmoud C, Xavier A, et al. Is KIR4.1 antibody a marker of multiple sclerosis? Neurology 2014; 82 (Suppl): P4.130.
16. Dhungana S, Sharrack B, Woodroofe N,. Cytokines and chemokines in idiopathic intracranial hypertension. Headache 2009; 49: 282-285.
17. Dhungana S, Sharrack B, Woodroofe N,. IL-1β TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clin Endocrinol 2009; 71: 896-897.
18. Ekizoglu E, Içoz S, Tuzun E, et al. Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia 2012; 32: 198-202.
19. Skau M, Brennum J, Gjerris F, et al. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2006; 26: 384-399.
20. Sartori S, Priante E, Pettenazzo A, et al. Intrathecal synthesis of oligoclonal bands in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome: New evidence supporting immunological pathogenesis. J Child Neurol 2014; 29: 421-425.
21. Da RR, Kao G, Guo WZ, et al. Polyclonal B-cell expansion in the cerebrospinal fluid of patients with pseudotumor cerebri. J Clin Immunol 2004; 24: 674-682.
22. Silberberg DH, Lateis AM,. Increased intracranial pressure in disseminated lupus erythematosus. Arch Neurol 1973; 29: 88-90.
23. Carlow TJ, Glaser JS,. Pseudotumor cerebri syndrome in systemic lupus erythematosus. JAMA 1974; 228: 197-200.
24. Mokri B, Jack CR Jr, Petty GW,. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies. Stroke 1993; 24: 469-472.
25. Sbeiti S, Kayed DM, Majuri H,. Pseudotumour cerebri presentation of systemic lupus erythematosus: More than an association. Rheumatology 2003; 42: 808-810.
26. Williams BJ, Skinner HJ, Maria BL,. Increased intracranial pressure in a case of pediatric multiple sclerosis. J Child Neurol 2008; 23: 699-702.
27. Newman NJ, Selzer KA, Bell RA,. Association of multiple sclerosis and intracranial hypertension. J Neuroophthalmol 1994; 14: 189-192.